CKD-506 is a histone deacetylase (HDAC) inhibitor which is under development for the treatment of inflammatory bowel diseases (IBDs) and rheumatoid arthritis. It acts as a selective HDAC6 inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.